Global Pharmatech (Global Pharmatech) Gross Profit : $1.47 Mil (TTM As of Jun. 2008)

Global Pharmatech Gross Profit Chart

Global Pharmatech Quarterly Data
	Mar03	Mar04	Sep04	Dec04	Mar05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08
Gross Profit	Get a 7-Day Free Trial												0.44	0.23	0.38	0.32	0.54

Competitive Comparison of Global Pharmatech's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Global Pharmatech's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Global Pharmatech's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Global Pharmatech's Gross Profit distribution charts can be found below:

* The bar in red indicates where Global Pharmatech's Gross Profit falls into.

Global Pharmatech Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Global Pharmatech's Gross Profit for the fiscal year that ended in Dec. 2007 is calculated as

Global Pharmatech's Gross Profit for the quarter that ended in Jun. 2008 is calculated as

Gross Profit for the trailing twelve months (TTM) ended in Jun. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.47 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Global Pharmatech's Gross Margin % for the quarter that ended in Jun. 2008 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Global Pharmatech  (OTCPK:GBLP) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Global Pharmatech had a gross margin of 73.49% for the quarter that ended in Jun. 2008 => Durable competitive advantage

Global Pharmatech Gross Profit Related Terms

Thank you for viewing the detailed overview of Global Pharmatech's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.

Global Pharmatech (Global Pharmatech) Business Description